Research indicates that knocking out ZC3H12A reprograms CD8+ T cells into a unique “long-lived effector” state, significantly enhancing their accumulation, persistent survival, and killing capacity at tumor sites [80]. This evidence concerns the gene ZC3H12A and neoplasm.